Research published in PMC confirms that the etiology of semaglutide-associated allodynia is "thought to be an error in the long-term potentiation of sensory nerves," directly implicating central sensitization as the primary mechanism
It lands on Schedule IV due to its phentermine component and has warnings about use in the setting of cardiovascular disease, in addition to concerns about topiramate side effects that include drowsiness, changes in sensation, and kidney stones
However, SYMLIN is indicated to be coadministered with mealtime insulin therapy, and in this setting there is an increased risk of severe hypoglycemia, particularly in patients with type 1 diabetes
Tailoring Therapy Toward the Management of Extraintestinal Manifestations of IBD: Neurological, Ocular, Cutaneous and Musculoskeletal
The effectiveness of semaglutide, along with tailored advice from your healthcare provider about managing appetite and improving metabolism, can lead to noticeable results over time
Number of mice per group for c : LF: 6, HF: 10, HF + Akk: 10